Semanteon Capital Management LP Acquires New Stake in Teleflex Incorporated (NYSE:TFX)

Semanteon Capital Management LP bought a new stake in Teleflex Incorporated (NYSE:TFX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 4,373 shares of the medical technology company's stock, valued at approximately $778,000.

Several other hedge funds also recently modified their holdings of TFX. Janus Henderson Group PLC increased its holdings in shares of Teleflex by 2.8% during the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company's stock worth $1,329,704,000 after acquiring an additional 147,147 shares during the last quarter. State Street Corp raised its position in shares of Teleflex by 1.0% in the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company's stock valued at $508,757,000 after buying an additional 21,291 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Teleflex by 0.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company's stock valued at $278,676,000 after purchasing an additional 5,746 shares in the last quarter. Cooke & Bieler LP grew its position in Teleflex by 22.1% in the fourth quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock valued at $191,962,000 after acquiring an additional 195,150 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA increased its position in Teleflex by 0.4% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company's stock worth $105,749,000 after purchasing an additional 1,884 shares in the last quarter. Institutional investors own 95.62% of the company's stock.

Remove Ads

Teleflex Stock Performance

TFX traded up $0.88 during trading on Wednesday, hitting $140.13. The company's stock had a trading volume of 747,532 shares, compared to its average volume of 552,531. The business's 50 day simple moving average is $161.64 and its 200-day simple moving average is $192.23. The firm has a market cap of $6.50 billion, a PE ratio of 27.86, a P/E/G ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a one year low of $128.55 and a one year high of $249.91. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX - Get Free Report) last released its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $795.40 million during the quarter, compared to analysts' expectations of $813.24 million. As a group, sell-side analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a dividend of $0.34 per share. The ex-dividend date was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 0.97%. Teleflex's payout ratio is currently 95.77%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on TFX. Wells Fargo & Company dropped their price target on shares of Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Citizens Jmp lowered Teleflex from an "outperform" rating to a "market perform" rating in a research report on Thursday, February 27th. Truist Financial cut their price objective on Teleflex from $200.00 to $149.00 and set a "hold" rating on the stock in a research report on Monday, March 3rd. Piper Sandler reissued a "neutral" rating and set a $140.00 price objective (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. Finally, Royal Bank of Canada lowered Teleflex from an "outperform" rating to a "sector perform" rating and cut their price target for the stock from $220.00 to $155.00 in a report on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $182.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.